Two major drug wholesalers recently agreed to pay millions of dollars to settle claims they failed to report suspicious orders for opioid painkillers to the Drug Enforcement Administration, according to NPR.
The head of the Drug Enforcement Administration is visiting China this week to discuss combating sales of synthetic drugs, including fentanyl, CNN reports. Acting Administrator Chuck Rosenberg will also discuss new psychoactive substances and money-laundering activities when he meets with Chinese officials.
In the past year, federal and state policymakers have taken a number of steps to combat synthetic drugs, also known as “novel psychoactive substances,” according to Jonathan Woodruff, Senior Legislative Attorney at the National Alliance for Model State Drug Laws.
The Drug Enforcement Administration has temporarily banned the synthetic drug Pink under federal law, according to NBC News. The agency has received reports of at least 46 confirmed deaths associated with the drug.
Thirteen drug distribution companies knew or should have known that hundreds of millions of prescription narcotic pills were ending up on the black market, according to an investigation by The Washington Post.
The Drug Enforcement Administration said this week it will reverse its decision to temporarily make kratom a Schedule I drug, NPR reports. The reversal comes in the wake of protests by advocates, scientists and kratom vendors.